In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or “reprogram” fibroblasts -; the most commonly found cells in skin and connective tissue -; into cells with similar properties to limb progenitor cells.
BioAegis scores $20m BARDA contract to develop ARDS therapy – Pharmaceutical Technology
ARDS causes a fluid build-up in the lungs resulting from a severe complication of pneumonia, sepsis, Covid-19, or trauma. Image Credit: Design_Cells / Shutterstock. The
October 17, 2023